{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:41:32Z","timestamp":1776084092235,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,26]]},"DOI":"10.7759\/cureus.86819","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T01:53:36Z","timestamp":1750989216000},"source":"Crossref","is-referenced-by-count":1,"title":["The Deadly Masquerade: Unveiling the Fatal Facade of the Great Imitator"],"prefix":"10.7759","author":[{"given":"Tyler R","family":"Ellett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Pippas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema B","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1959832","article-title":"IgG4-related sclerosing cholangitis: rarely diagnosed, but not a rare disease","volume":"2021","author":"Drazilova S","year":"2021","unstructured":"Drazilova S, Veseliny E, Lenartova PD, et al.. IgG4-related sclerosing cholangitis: rarely diagnosed, but not a rare disease. Can J Gastroenterol Hepatol. 2021, 2021:1959832. 10.1155\/2021\/1959832","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr4428","article-title":"Isolated type immunoglobulin G4 sclerosing cholangitis: the misdiagnosed cholangiocarcinoma","volume":"13","author":"Nasser R","year":"2021","unstructured":"Nasser R, Gilshtein H, Mansour S, Yasin K, Borzellino G, Khuri S. Isolated type immunoglobulin G4 sclerosing cholangitis: the misdiagnosed cholangiocarcinoma. J Clin Med Res. 2021, 13:75-81. 10.14740\/jocmr4428","journal-title":"J Clin Med Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.793","article-title":"Epidemiological features of immunoglobulin G4-related sclerosing cholangitis in Japan","volume":"27","author":"Tanaka A","year":"2020","unstructured":"Tanaka A, Mori M, Kubota K, et al.. Epidemiological features of immunoglobulin G4-related sclerosing cholangitis in Japan. J Hepatobiliary Pancreat Sci. 2020, 27:598-603. 10.1002\/jhbp.793","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.12.038","article-title":"Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis","volume":"15","author":"Tanaka A","year":"2017","unstructured":"Tanaka A, Tazuma S, Okazaki K, Nakazawa T, Inui K, Chiba T, Takikawa H. Clinical features, response to treatment, and outcomes of IgG4-related sclerosing cholangitis. Clin Gastroenterol Hepatol. 2017, 15:920-6.e3. 10.1016\/j.cgh.2016.12.038","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande V","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al.. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012, 25:1181-92. 10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocpiqo.2021.03.005","article-title":"Diagnosing biliary strictures: distinguishing IgG4-related sclerosing cholangitis from cholangiocarcinoma and primary sclerosing cholangitis","volume":"5","author":"Hori Y","year":"2021","unstructured":"Hori Y, Chari ST, Tsuji Y, et al.. Diagnosing biliary strictures: distinguishing IgG4-related sclerosing cholangitis from cholangiocarcinoma and primary sclerosing cholangitis. Mayo Clin Proc Innov Qual Outcomes. 2021, 5:535-41. 10.1016\/j.mayocpiqo.2021.03.005","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort","volume":"109","author":"Huggett MT","year":"2014","unstructured":"Huggett MT, Culver EL, Kumar M, et al.. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014, 109:1675-83. 10.1038\/ajg.2014.223","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5107(04)02229-1","article-title":"Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis","volume":"60","author":"Nakazawa T","year":"2004","unstructured":"Nakazawa T, Ohara H, Sano H, et al.. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc. 2004, 60:937-44. 10.1016\/s0016-5107(04)02229-1","journal-title":"Gastrointest Endosc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14151621","article-title":"Endoscopic retrograde cholangiopancreatography-related procedures for the differential diagnosis of isolated immunoglobin G4-related sclerosing cholangitis and perihilar cholangiocarcinoma","volume":"14","author":"Furukawa M","year":"2024","unstructured":"Furukawa M, Ishii Y, Tatsukawa Y, et al.. Endoscopic retrograde cholangiopancreatography-related procedures for the differential diagnosis of isolated immunoglobin G4-related sclerosing cholangitis and perihilar cholangiocarcinoma. Diagnostics (Basel). 2024, 14:1621. 10.3390\/diagnostics14151621","journal-title":"Diagnostics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2015.10.024","article-title":"Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma","volume":"71","author":"Yata M","year":"2016","unstructured":"Yata M, Suzuki K, Furuhashi N, Kawakami K, Kawai Y, Naganawa S. Comparison of the multidetector-row computed tomography findings of IgG4-related sclerosing cholangitis and extrahepatic cholangiocarcinoma. Clin Radiol. 2016, 71:203-10. 10.1016\/j.crad.2015.10.024","journal-title":"Clin Radiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2021-0113","article-title":"Immunoglobulin G4-related disease: a new systemic disease emerging in Japan","volume":"5","author":"Kamisawa T","year":"2022","unstructured":"Kamisawa T. Immunoglobulin G4-related disease: a new systemic disease emerging in Japan. JMA J. 2022, 5:23-35. 10.31662\/jmaj.2021-0113","journal-title":"JMA J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.12.10360","article-title":"Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis","volume":"202","author":"Tokala A","year":"2014","unstructured":"Tokala A, Khalili K, Menezes R, Hirschfield G, Jhaveri KS. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. AJR Am J Roentgenol. 2014, 202:536-43. 10.2214\/AJR.12.10360","journal-title":"AJR Am J Roentgenol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue D","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, et al.. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015, 94:e680. 10.1097\/MD.0000000000000680","journal-title":"Medicine (Baltimore)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2021.02.009","article-title":"Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: comparison of cases with and without autoimmune pancreatitis in a large cohort","volume":"53","author":"Naitoh I","year":"2021","unstructured":"Naitoh I, Kamisawa T, Tanaka A, et al.. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: comparison of cases with and without autoimmune pancreatitis in a large cohort. Dig Liver Dis. 2021, 53:1308-14. 10.1016\/j.dld.2021.02.009","journal-title":"Dig Liver Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-014-0945-z","article-title":"Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis","volume":"49","author":"Kamisawa T","year":"2014","unstructured":"Kamisawa T, Okazaki K, Kawa S, et al.. Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol. 2014, 49:961-70. 10.1007\/s00535-014-0945-z","journal-title":"J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale A","year":"2008","unstructured":"Ghazale A, Chari ST, Zhang L, et al.. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008, 134:706-15. 10.1053\/j.gastro.2007.12.009","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.1404","article-title":"IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: a multicenter cohort study","volume":"31","author":"Kurita Y","year":"2024","unstructured":"Kurita Y, Kubota K, Fujita Y, et al.. IgG4-related pancreatobiliary diseases could be associated with onset of pancreatobiliary cancer: a multicenter cohort study. J Hepatobiliary Pancreat Sci. 2024, 31:173-82. 10.1002\/jhbp.1404","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409712","article-title":"Inebilizumab for treatment of IgG4-related disease","volume":"392","author":"Stone JH","year":"2025","unstructured":"Stone JH, Khosroshahi A, Zhang W, et al.. Inebilizumab for treatment of IgG4-related disease. N Engl J Med. 2025, 392:1168-77. 10.1056\/NEJMoa2409712","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376412-the-deadly-masquerade-unveiling-the-fatal-facade-of-the-great-imitator","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T01:53:37Z","timestamp":1750989217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376412-the-deadly-masquerade-unveiling-the-fatal-facade-of-the-great-imitator"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.86819","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}